Skip to content

Effectiveness of Transauricular Vagus Nerve Stimulation in Alleviating Postoperative Pain in Elderly Patients Undergoing Hip Replacement Surgery via Autonomic Nervous System Modulation: A Randomized, Double-Blind, Controlled Study

Effectiveness of Transauricular Vagus Nerve Stimulation in Alleviating Postoperative Pain in Elderly Patients Undergoing Hip Replacement Surgery via Autonomic Nervous System Modulation: A Randomized, Double-Blind, Controlled Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091530
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Interventions

active stimulation group:The active stimulation group received electrical stimulation of the left cymba conchae at a frequency of 30 Hz, pulse width of 250 µs, in a 30-second on/30-second off cycle, f
sham stimulation group :The sham stimulation group underwent the same treatment cycle, with electrodes positioned on the left cymba conchae, utilizing the same method to adjust the stimulation intensi

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Aged 65 to 85 years. 2.Diagnosed with a hip fracture and scheduled for elective hip replacement under general anesthesia at this hospital. 3.Willing to participate and provide informed consent. 4.ASA (American Society of Anesthesiologists) classification of 1-3. 5.Capable of understanding study procedures and evaluation scales, and able to communicate effectively with research staff.

Exclusion criteria

Exclusion criteria: 1.Patients with arrhythmias that require treatment. 2.Patients with neuromuscular disorders or dermatitis of the left auricle. 3.History of opioid or substance use disorder. 4.Patients unable to comply with assessments. 5.Seizure episodes or recurrent syncope within the last 5 years. 6.History of transient ischemic attack (TIA) or cerebrovascular accident (stroke). 7.Patients who have undergone vagus nerve stimulation or acupuncture in the past month. 8.Patients currently enrolled in other clinical trials. 9.Vulnerable populations, including those with psychiatric disorders, cognitive impairment, critical illness, minors, pregnant women, or illiterate individuals.

Design outcomes

Primary

MeasureTime frame
Postoperative 24-hour sufentanil consumption;

Secondary

MeasureTime frame
Cumulative consumption of analgesic pump sufentanil;Postoperative sleep quality;Quality of Recovery;Postoperative pain;

Countries

China

Contacts

Public ContactGang Chen

Department of Anesthesiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, China

chengang120@zju.edu.cn+86 137 5711 8681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026